glp 1 for bulimia GLP-1 receptor agonists: A novel pharmacotherapy binge eating (Binge eating disorder and nervosa)? A systematic review GLP1-RA and Pediatric Populations: Psychosocial

3B and Movie EV2)

Glutathione taken orally has: Variable absorption Potential breakdown in the digestive tract Some studies show limited bioavailability, though newer forms (like liposomal glutathione) may improve this (Sinha et al., Eur J Clin Nutr, 2018)

Exercise volume (47 days per week, with 35 sessions of resistance training) substantially above population norms

GLP-1s are primarily for treating type 2 diabetes, obesity, cardiovascular disease, and sleep apnea

1 The FDA plans to hold a public meeting on June 4, 2026, to discuss the ongoing implementation and criteria of the CNPV program following this historic first NME approval

2003, Aitken & Baker 2006, Valko et al